Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Epic American Credit and Bond Bubble Laboratory -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (36442)	7/20/2005 9:51:47 PM
From: loantech	Read Replies (1) \| Respond to of 110194

What does sensitive mean?

To: Henry Niman who wrote (36442)	7/20/2005 9:53:51 PM
From: Jim McMannis	Read Replies (1) \| Respond to of 110194

Britain to stockpile two million bird flu vaccines Wed Jul 20,11:23 AM ET LONDON (AFP) - Britain is to stockpile two million doses of a bird flu vaccine in case an epidemic of the disease sweeps the globe. Manufacturers are to be invited to submit tenders for a contract to supply the H5N1 vaccine, to be used as a "first line of defence" in any outbreak, Health Secretary Patricia Hewitt said Wednesday. The vaccines would be used mainly to protect key medical and emergency workers. The H5N1 strain of bird flu has so far been mainly transmitted between animals, but it has also killed more than 50 people in Southeast Asia since 2003. Experts fear it could mutate into a highly infectious strain that can be easily transmitted from animals to humans or from humans to humans, unleashing a pandemic that could kill tens of millions of people. On Wednesday, Indonesia became the latest country to confirm human deaths from bird flu. "I have decided it would be prudent to purchase a limited quantity of H5N1 vaccine which could be used to help protect those that need it most, such as NHS (National Health Service) workers," Hewitt said. "We will also be able to carry out further research so that we can find out how the vaccine can be used most effectively."